Developing a sustainable process to provide quality control materials for genetic testing

被引：44

作者：

Chen, B ^{[1
]}

O'Connell, CD ^{[1
]}

Boone, DJ ^{[1
]}

Amos, JA ^{[1
]}

Beck, JC ^{[1
]}

Chan, MM ^{[1
]}

Farkas, DH ^{[1
]}

Lebo, RV ^{[1
]}

Richards, CS ^{[1
]}

Roa, BB ^{[1
]}

Silverman, LM ^{[1
]}

Barton, DE ^{[1
]}

Bejjani, BA ^{[1
]}

Belloni, DR ^{[1
]}

Bernacki, SH ^{[1
]}

Caggana, M ^{[1
]}

Charache, P ^{[1
]}

Dequeker, E ^{[1
]}

Ferreira-Gonzalez, A ^{[1
]}

Friedman, KJ ^{[1
]}

Greene, CL ^{[1
]}

Grody, WW ^{[1
]}

Highsmith, WE ^{[1
]}

Hinkel, CS ^{[1
]}

Kalman, LV ^{[1
]}

Lubin, IM ^{[1
]}

Lyon, E ^{[1
]}

Payne, DA ^{[1
]}

Pratt, VM ^{[1
]}

Rohlfs, E ^{[1
]}

Rundell, CA ^{[1
]}

Schneider, E ^{[1
]}

Willey, AM ^{[1
]}

Williams, LO ^{[1
]}

Willey, JC ^{[1
]}

Winn-Deen, ES ^{[1
]}

Wolff, DJ ^{[1
]}

机构：

[1] Ctr Dis Control & Prevent, Atlanta, GA 30341 USA

来源：

GENETICS IN MEDICINE | 2005年 / 7卷 / 08期

关键词：

genetic testing; quality assurance; quality control; quality control materials; reference materials;

D O I：

10.1097/01.GIM.0000183043.94406.81

中图分类号：

Q3 [遗传学];

学科分类号：

071007 ; 090102 ;

摘要：

Purpose: To provide a summary of the outcomes of two working conferences organized by the Centers for Disease Control and Prevention (CDC), to develop recommendations for practical, sustainable mechanisms to make quality control (QC) materials available to the genetic testing community. Methods: Participants were selected to include experts in genetic testing and molecular diagnostics from professional organizations, government agencies, industry, laboratories, academic institutions, cell repositories, and proficiency testing (PT)/external Quality Assessment (EQA) programs. Current efforts to develop QC materials for genetic tests were reviewed; key issues and areas of need were identified; and workgroups were formed to address each area of need and to formulate recommendations and next steps. Results: Recommendations were developed toward establishing a sustainable process to improve the availability of appropriate QC materials for genetic testing, with an emphasis on molecular genetic testing as an initial step. Conclusions: Improving the availability of appropriate QC materials is of critical importance for assuring the quality of genetic testing, enhancing performance evaluation and PT/EQA programs, and facilitating new test development. To meet the needs of the rapidly expanding capacity of genetic testing in clinical and public health settings, a comprehensive, coordinated program should be developed. A Genetic Testing Quality Control Materials Program has therefore been established by CDC in March 2005 to serve these needs.

引用

页码：534 / 549

页数：16

共 38 条

[1]

ACOG Committee on Genetics, 2004, Obstet Gynecol, V104, P425

[2]

*AM COLL MED GEN, AM COLLMED GEN STAND

[3]

*AM COLL MED GEN, AM COLL MED GEN TECH

[4]

[Anonymous], 2001, PREC PREN CARR SCREE

[5]

[Anonymous], BEST PRACT GUID

[6]

*ASS MOL PATH, FDA APPR MOL DIAGN T

[7]

BECK JC, 3 QC MAT GEN TEST WO

[8] Establishment of stably EBV-transformed cell lines from residual clinical blood samples for use in performance evaluation and quality assurance in molecular genetic testing [J].

Bernacki, SH ;

Stankovic, AK ;

Williams, LO ;

Beck, JC ;

Herndon, JE ;

Snow-Bailey, K ;

Prior, TW ;

Matteson, KJ ;

Wasserman, LM ;

Cole, EC ;

Stenzel, TT .

JOURNAL OF MOLECULAR DIAGNOSTICS, 2003, 5 (04) :227-230

[9]

*CDCP, 2005, GEN TEST QUAL CONTR

[10]

*CFTR MUT PAN, COR CELL REP

← 1 2 3 4 →